Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases. - Wikidata - awgldk - TriplyDB

Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.

Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.

http://www.wikidata.org/entity/Q37976848

about

The Need for Pediatric Formulations to Treat Children with HIV Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies.A quantitative ethnopharmacological documentation of natural pharmacological agents used by pediatric patients in Mauritius.Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art.Cyclodextrin complexes for treatment improvement in infectious diseases.Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients.Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect.Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid.Production of pure indinavir free base nanoparticles by a supercritical anti-solvent (SAS) method.

P2860

Q26740369-FF3DDA44-97C2-413C-B102-B2D6608D792D Q28821119-78C88451-DF29-4981-AEF6-B6C8776EDE4C Q33737313-806CCDF5-55D2-4A72-A898-B9D7D43591A2 Q38237646-DBA22677-BA0C-4BD9-A33C-7338633D5E4D Q38501664-BFF0C589-BA72-42BD-B10F-C00B42CC1347 Q38545613-1914E0C6-4C45-486A-A2B6-B136AD1BBB2E Q40377157-A937DC14-9168-43F3-97F3-2729770420CD Q41023286-7D01BC4F-E712-4200-BDFA-FC5F55002200 Q43882895-ECDFC550-D5B9-4AD3-8B11-B54C93CC1101 Q44673149-AA70D76D-1FC3-4500-AC8F-71DB72667007

P2860

Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.

http://www.wikidata.org/entity/Q37976848

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel formulation and drug del ...... tric poverty-related diseases.

@en

Novel formulation and drug del ...... tric poverty-related diseases.

@nl

type

label

Novel formulation and drug del ...... tric poverty-related diseases.

@en

Novel formulation and drug del ...... tric poverty-related diseases.

@nl

prefLabel

Novel formulation and drug del ...... tric poverty-related diseases.

@en

Novel formulation and drug del ...... tric poverty-related diseases.

@nl

P1433

Q37976848-9C93C8A6-0A98-493B-958C-21259BDB8E2D

P1476

Q37976848-841CB0C9-006B-4750-AB16-576FA021C442

P2093

Q37976848-37F3DD8F-9358-4AC9-878F-D92EEA1733DA

Q37976848-A5B9E355-B3BE-46BD-9D05-907D2D1DE491

Q37976848-E036B39F-E036-4CE5-828E-C29FED5510DF

P2860

Q37976848-014A1C87-E519-430B-80E3-C40588B9E535

Q37976848-04BC6912-BBD2-4738-AB66-DC984565DFF5

Q37976848-05108C6F-D92D-4698-BB91-E59A428282D1

Q37976848-06A9F9AD-10F2-482D-BEFA-2E785CBDFADB

Q37976848-0A8D8B8C-F75A-4C53-8649-107F8FEF8C48

Q37976848-0E5EB1B2-7C57-47E3-8821-DEC18E4B0E8C

Q37976848-0F30B2F8-E330-4E2C-8F0E-2603B79E1D62

Q37976848-10B75044-01A0-4CCC-87A6-CA428743FBC1

Q37976848-13E7BB99-AEDE-4CB2-A68C-124C9BF3D873

Q37976848-18EA53FD-A59C-4215-B313-6B5EA6A6F830

P304

Q37976848-26078A33-9B8B-4E4B-A601-E88D48404264

P31

Q37976848-87C4C90F-08EA-414A-9E7A-55E2E97ACFC8

P356

Q37976848-66908B80-F805-43A8-88B8-AF2B485E082E

P407

Q37976848-CBEC0C97-405D-4EDF-8ECB-C028A3A71793

P433

Q37976848-44203105-58F9-427B-9026-333F3203ABC9

P478

Q37976848-9BC86602-E650-4506-BF61-ED035072D7E9

P50

Q37976848-4EE65AA7-9D64-4498-8A92-6C213EF26027

P577

Q37976848-76E8AE79-22B8-42D2-84C8-256B1491DCE7

P5875

Q37976848-D3B83C93-0AFB-4F1D-9675-2EECBAD44568

P698

Q37976848-F6BDE59C-5D96-4B6A-BE6F-4FA186BD5BFB

P921

Q37976848-7876B91C-BE67-45A2-A7BF-1E0E89001A69

Q37976848-C38E54DD-FC87-4C8A-AAF7-75121F875ABD

P356

17425247.2012.655268

P1433

Expert Opinion on Drug Delivery

P1476

Novel formulation and drug del ...... tric poverty-related diseases.

@en

P2093

Alejandro Sosnik

http://www.w3.org/2001/XMLSchema#string

Diego A Chiappetta

http://www.w3.org/2001/XMLSchema#string

Julieta C Imperiale

http://www.w3.org/2001/XMLSchema#string

P2860

Micro-scale devices for transdermal drug delivery

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo.

Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.

Inhalable microparticles containing large payload of anti-tuberculosis drugs.

The economics of pediatric formulation development for off-patent drugs.

The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.

Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children.

Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects

P304

303-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.2012.655268

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Katia P Seremeta

P577

2012-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221758808

http://www.w3.org/2001/XMLSchema#string

P698

22257003

http://www.w3.org/2001/XMLSchema#string

P921